Ibuprofen Bruis Linn

Ibuprofen, the active ingredient in Ibuprofen Bruis Linn, is a nonsteroidal anti-inflammatory drug (NSAID) presented as an oral formulation for oral use. It provides analgesic, antipyretic, and anti‑inflammatory effects for adults experiencing mild to moderate pain, fever, or inflammatory joint conditions.

GNH USA supplies Ibuprofen Bruis Linn as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide. The company adheres to stringent quality standards and provides regulatory documentation to support import and distribution in multiple jurisdictions globally.

Ibuprofen acts systemically to reduce inflammation and pain by inhibiting cyclooxygenase enzymes, making it useful for several common conditions.

Mild to moderate pain: provides analgesic relief for headaches, dental pain, musculoskeletal discomfort, and postoperative pain. Fever: lowers elevated body temperature associated with infections or inflammatory states. Arthritic inflammation: diminishes joint swelling and improves mobility in osteoarthritis and rheumatoid arthritis.

Ibuprofen may cause a range of adverse reactions, varying from mild and transient to serious and potentially life‑threatening.

Common Side Effects: - Gastrointestinal discomfort: nausea, dyspepsia, or abdominal pain. - Headache: mild to moderate intensity. - Dizziness or vertigo.

Serious or Rare Side Effects: - Gastrointestinal bleeding or ulcer perforation. - Acute renal failure or worsening of chronic kidney disease. - Severe allergic reactions such as anaphylaxis or Stevens‑Johnson syndrome.

When using ibuprofen, several precautionary measures should be observed to minimize risk and ensure safe therapy. - Assess renal function: evaluate kidney health before initiating therapy, especially in patients with existing renal impairment. - Monitor gastrointestinal risk: avoid use in individuals with a history of peptic ulcer disease or gastrointestinal bleeding. - Use cautiously with anticoagulants: increased bleeding risk when combined with warfarin, clopidogrel, or similar agents. - Consider asthma status: ibuprofen may exacerbate symptoms in patients with aspirin‑sensitive asthma. - Review pregnancy and lactation: consult a healthcare professional before use during pregnancy or breastfeeding. - Store at ambient temperature: keep the product in its original packaging, protect from moisture and direct heat.

Ibuprofen can interact with several medicines, altering efficacy or safety; interactions are categorized by clinical significance.

Major Interactions (Avoid): - Anticoagulants (e.g., warfarin, direct oral anticoagulants): heightened risk of serious bleeding. - High‑dose aspirin or selective COX‑2 inhibitors: additive gastrointestinal and renal toxicity. - Lithium: ibuprofen may increase serum lithium concentrations, risking toxicity.

Moderate Interactions (Monitor Closely): - ACE inhibitors or ARBs: concurrent use may reduce renal function, especially in volume‑depleted patients. - Diuretics: may potentiate electrolyte disturbances and renal impairment. - Methotrexate: ibuprofen can decrease renal clearance, raising methotrexate levels.